NCT02843542View on ClinicalTrials.gov

Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI)

NAUnknownINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

December 31, 2018

Conditions
Primary Hyperthyroidism
Interventions
DEVICE

PET-MR

Patients with Hyperthyroidism and surgery indication will be recruited and directed to imagine exams. In addition to the conservative 99mTc-MIBI and US, patients will also undergo 18FCH PET/MRI for detecting adenomas and their location.

DEVICE

PET-CT

Patients with Hyperthyroidism and surgery indication will be recruited and directed to imagine exams. In addition to the conservative 99mTc-MIBI and US, patients will also undergo PET-CT for detecting adenomas and their location.

Trial Locations (1)

Unknown

Assuta Medical Center, Tel Aviv

Sponsors
All Listed Sponsors
lead

Assuta Medical Center

OTHER

NCT02843542 - Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI) | Biotech Hunter | Biotech Hunter